Abstract
Neonatal alcohol exposure in rodents causes dramatic neurodegenerative effects throughout the developing nervous system, particularly in the striatum, acutely after exposure. These acute neurodegenerative effects are augmented in mice lacking adenylyl cyclases 1 and 8 (AC1/8) as neonatal mice with a genetic deletion of both AC isoforms (DKO) have increased vulnerability to ethanol-induced striatal neurotoxicity compared to wild type (WT) controls. While neonatal ethanol exposure is known to negatively impact cognitive behaviors, such as executive functioning and working memory in adolescent and adult animals, the threshold of ethanol exposure required to impinge upon developmental behaviors in mice has not been extensively examined. Therefore, the purpose of this study was to determine the behavioral effects of neonatal ethanol exposure using various striatal-dependent developmental benchmarks and to assess the impact of AC1/8 deletion on this developmental progression. WT and DKO mice were treated with 2.5 g/kg ethanol or saline on postnatal day (P)6 and later subjected to the wire suspension, negative geotaxis, postural reflex, grid hang, tail suspension and accelerating rotarod tests at various time points. At P30, mice were evaluated for their hypnotic responses to 4.0 g/kg ethanol by using the loss of righting reflex assay and ethanol-induced stimulation of locomotor activity after 2.0 g/kg ethanol.
Ethanol exposure significantly impaired DKO performance in the negative geotaxis test while genetic deletion of AC1/8 alone increased grid hang time and decreased immobility time in the tail suspension test with a concomitant increase in hindlimb clasping behavior. Locomotor stimulation was significantly increased in animals that received ethanol as neonates, peaking significantly in ethanol-treated DKO mice compared to ethanol-treated WT controls, while sedation duration following high-dose ethanol challenge was unaffected.
These data indicate that the maturational parameters examined in the current study may not be sensitive enough to detect effects of a single ethanol exposure during the brain growth spurt period. Genetic deletion of AC1/8 reveals a role for these cylases in attenuating ethanol-induced behavioral effects in the neonatally-exposed adolescent.
Keywords: Fetal Alcohol Spectrum Disorders (FASD), Adenylyl Cyclase, Ethanol, Behavior, Striatum
1. Introduction
Exposure of a developing fetus to alcohol can result in a wide range of both physical and mental impairments, termed fetal alcohol spectrum disorders (FASD), that include craniofacial abnormalities, growth deficits, mental retardation, and behavioral alterations. [1–11]. Numerous human imaging studies have demonstrated overall reductions in brain volume, with distinct vulnerability in the cerebellum, corpus callosum, cortex, hippocampus, and basal ganglia, (reviewed in [12]). These reductions in brain volume have been recapitulated and further investigated using animal models of FASD. These studies demonstrate pronounced and wide-spread cell death following neonatal alcohol exposure in similar brain regions to those affected in human studies [13–22], with the striatum showing heightened sensitivity to neurodegeneration after a single exposure to 2.5 or 5.0 g/kg ethanol [22, 23].
The cortico-striatal damage observed in children with FASD is often associated with deficits in various cognitive behaviors [24, 25]. Many studies have also demonstrated motor dysfunction including weak grasp, balance and gait impairments, delayed reaction time and deficiencies in coordination, which involve both the cerebellum and the basal ganglia (reviewed in [7]). In the current study, we performed a battery of tests to determine if a single neonatal ethanol exposure (2.5 g/kg), which has been shown to result in significant cell death in the striatum, could affect various striatal-dependent behaviors. First, we assessed developmental milestones, such as the postural reflex, negative geotaxis, and wire suspension tests. Additionally, we performed the grid hang test which is sensitive to reductions in striatal dopamine and its metabolites, a condition that is known to occur in a model of Parkinson’s disease and rat models of FASD [26–29]. The tail suspension test was used to examine the presence of hindlimb clasping, which can result from ethanol-induced striatal excitotoxicity in neonates [30], a phenotype similar to that exhibited in models of Huntington’s disease, in which high levels of medium spiny neuron depletion in the striatum has been reported [31]. Finally, the effects of neonatal ethanol exposure on locomotor activation by low-dose ethanol and sedation by high-dose ethanol during adolescence were also evaluated.
To further examine mechanisms that might underlie striatal-related behavioral deficits resulting from neonatal ethanol exposure, we evaluated mice lacking the calcium/calmodulin-stimulated adenylyl cyclases (ACs) 1 and 8 (DKO). These mice demonstrate increased vulnerability to ethanol-induced neurotoxicity in the developing striatum, which is associated with a decrease in the phosphorylation of the pro-survival proteins insulin-receptor substrate-1, extracellular related kinase, and Akt, compared to wild type (WT) controls [23]. Therefore, these animals are ideal to study the threshold in neurodegeneration required for behavioral effects to become evident. Similarly, these mice demonstrate increased sensitivity to high-dose ethanol sedation and resistance to stimulation by low-dose ethanol, substantiating a role for AC1 and 8 in mediating ethanol-induced behaviors [32–34].
2. Methods
2.1 Animals
All mice were backcrossed a minimum of ten generations to WT C57BL/6J mice from The Jackson Laboratory (Bar Harbor, ME). To generate mice for these experiments, homozygous mutants, DKO, and WT mice were bred in-house. Mice were maintained on a 12-h light/dark schedule with ad libitum access to food and water. All mouse protocols were in accordance with the National Institutes of Health guidelines and were approved by the Institutional Animal Care and Use Committee at Wayne State University.
2.2 Ethanol Treatment
A single dose of ethanol (2.5 g/kg), prepared as a 20% (v/v) solution using 100% ethanol (Decon Laboratories, King of Prussia, PA) in 0.9% saline was injected subcutaneously into male WT and DKO pups [23]. Corresponding volumes of saline were administered to littermate male pups as controls. Only animals weighing 2.5–3.0 g between postnatal day (P)5 and P7 were used in these experiments. Ethanol exposure during P5–P7 represents maternal exposure to ethanol during the third trimester in humans. We have previously demonstrated that this treatment results in blood alcohol concentrations (BAC) of 276 ± 5 mg/dL in WT pups and 262 ± 9 mg/dL in DKO pups 15 min after injection [35]. Only 1 mouse per condition was used from each litter. One cohort of animals were tested for the postural reflex, negative geotaxis, wire suspension, grid hang, and tail suspension tests were treated with ethanol or saline at P6 only to maintain equal time between treatment and behavioral testing, which began at P7. Two addition groups of animals, used for rotarod and loss of righting reflex tests and locomotor activity monitoring, were treated with a single injection of ethanol or saline during P5–P7 (Table 1). All experimental pups were placed on a heating pad at 31°C [22] away from dams until the ethanol pups regained consciousness (~2 h), at which time all pups were returned to their dams. All pups were weaned at P21.
Table 1. Summary of behavioral tasks by group, treatment age, and age at testing.
The number of animals treated in each group is listed, along with the behavioral tests. X indicates the task was administered at the particular age. Timing of neonatal ethanol exposure was critical for the developmental tasks that were initiated on P7, therefore pups that were used for these studies (group 1) were injected only on P6. For the remainder of the studies (groups 2 and 3), the behavioral endpoint(s) did not occur until P30 allowing for treatment during the wider time frame, P5–P7.
| Group | Age Treated |
N | Behavioral Test | Ages Tested | ||||
|---|---|---|---|---|---|---|---|---|
| P7 | P10 | P14 | P21 | P30 | ||||
| 1 | P6 | 5–8 | Body Weight | X | X | X | X | X |
| Postural Reflex | X | X | X | X | X | |||
| Wire Suspension Negative Geotaxis | X | X | X | X | X | |||
| Negative Geotaxis | X | X | X | X | X | |||
| Grid Hang | X | X | X | |||||
| TST | X | X | X | |||||
| 2 | P5–P7 | 6–9 | Rotarod | X | ||||
| LORR | X | |||||||
| 3 | P5–P7 | 9–20 | LMA | X | ||||
2.3 Behavioral Tests
Saline and ethanol treated animals at P7, P10, P14, P21 and P30 were weighed and subjected to the wire suspension, negative geotaxis, and postural reflex tests. Additionally at P14, P21 and P30 mice were tested in the grid hang and tail suspension tests. All tests were separated by at least 10 min. Independent groups of mice were also tested at P30 for accelerating rotarod performance and loss of righting reflex, or ethanol-induced locomotor activity (Table 1).
2.3.1 Postural Reflex
Each mouse was placed on 4 paws in a 12 × 8 cm box, which was quickly moved in 2 dimensions (up/down, left/right). The animal was monitored for splaying of feet, and scored as follows: 0 = no splaying present, 1 = splaying present.
2.3.2 Wire Suspension (WS)
Each mouse was hung from a 3 mm wire from its forepaws. The ability to grasp the wire (0 = not present, 1 = present), and the time for which the wire was held (max = 30 s) was recorded. Each mouse must hold the wire for at least 1 s to be included in the time analysis.
2.3.3 Negative Geotaxis
Each animal was placed with its head facing downward on a 28 × 36 cm wire grid with 0.5 cm2 openings that was set at a 45° angle. The behavior of the animal was recorded for 30 s and scored as follows: 0 = turns and climbs, 1 = turns and freezes, 2 = moves, but fails to turn, 3 = does not move. The latency to turn and initiate climbing was also recorded for all animals that received a score of 0.
2.3.4 Grid Hang
Each mouse was placed on the center of a 0.5 cm2 grid at the bottom of a 28 × 36 cm box. The mouse was supported by the experimenter until it grabbed the grid with both its fore- and hindpaws. The grid was then inverted so the mouse was hanging upside-down. The duration of time that the animal remained on the grid was recorded. Only mice capable of hanging onto the grid for at least 1 s were included in analysis.
2.3.5 Tail-Suspension Test (TST)
Each animal was fastened by the tail using labeling tape (Fisher Scientific, Pittsburg, PA) to a metal rod ~30 cm above a bench top. The activity of the animal was recorded for 5 min and analyzed for total immobility time [36] and number of hindlimb clasping events (lasting for more than 1 s per event).
2.3.6 Accelerating Rotarod
At P30, motor performance was evaluated using an accelerating Mouse Rotarod (Ugo Basile, Collegeville, PA). The rod (3 cm in diameter and 14 cm above a platform) accelerated from 3.5 rotations per minute (RPM) to 36 RPM at a constant rate over a 5 min testing interval. Latency to fall from the rotating rod or to traverse around the rod for one full rotation was recorded for each mouse.
2.3.7 Loss of Righting Reflex Assay (LORR)
One h after completing the rotarod task, mice were given an injection intraperitoneally (i.p.) of 4.0 g/kg ethanol (prepared as a 20% (v/v) solution using 100% ethanol (Decon Labs, King of Prussia, PA) in 0.9% saline), and placed on their back in a U-shaped trough after losing the ability to right themselves. Duration of LORR (sedation time) was measured from the time the animals lost the righting reflex until this reflex was regained. Sedation time is defined as the time needed to regain the ability to right onto three of four paws, three times within 30 s.
2.3.8 Locomotor Activity Testing (LMA)
At P30, locomotor activity was measured within a 46 cm × 26 cm polycarbonate cage. An automated monitoring system (Digiscan DMicro, Accuscan Instruments, Columbus, OH) consisting of 16 parallel infrared emitter/detector photocells was used to measure activity. This automated measure of activity was transformed into 1 min blocks over the duration of the session. The spontaneous locomotor activity of each animal was monitored for 10 min on days 1–4, immediately following injection of 0.9% saline. On day 5, animals were given an i.p. injection of 2.0 g/kg ethanol (20% (v/v) solution in 0.9% saline), immediately placed in the activity monitor chambers and activity was measured for 10 min. Previous studies using DKO animals have demonstrated a significant increase in baseline locomotor activity compared to WT mice [34], therefore locomotor activity levels were analyzed as a percent of respective neonatal saline-treated controls.
2.4 Statistical Analysis
Mice that did not meet the minimum inclusion criteria (stated above for each task) were eliminated before statistical analysis was performed. Three-way repeated measures ANOVA was used for body weight, grid hang time, WS time and TST immobility time with Genotype and Treatment as the between subject factors and Age as the within subjects factor. Three-way repeated measures ANOVAs were also used for LMA activity with Genotype and Treatment as the between subjects factors, and Day or Minute as the within subjects factor. Two-way ANOVA was used for latency to fall from the rotarod and sedation time (LORR) with Genotype and Treatment as the between subject factors. A two-way ANOVA was also performed for the latency to turn in the negative geotaxis test at each time point because not all the mice could perform the task at each time point, invalidating a three-way ANOVA. Statistical analysis on the postural reflex task was not performed because all animals were scored a 1 (capable of splaying the feet) at every time point examined.
Results
3.1 Body Weight
The body weight of each animal from group 1 was determined before each day of behavioral testing and was found to significantly increase with age (Fig 1), with no significant effects for either genotype or treatment (Three-way ANOVA, χ2 = 55.05, p<0.001, Greenhouse-Geisser correction ε=0.40 [p<0.001; corrected F(1.58, 26.9)=737.66).
Figure 1. Average body weight measurements through duration of behavioral testing.
Body weight significantly increased with age in all groups examined with no significant effect of Genotype or ethanol (EtOH) Treatment. Mean ± SEM, n=5–8 mice per group.
3.2 Postural Reflex
Neither neonatal ethanol exposure nor genotype had an effect on postural reflex as demonstrated by all animals splaying all four feet as early as one day after ethanol treatment (P7) and continuing through P30 (data not shown).
3.3 Wire Suspension
Age significantly affected the formation of this reflex, with mice not being capable of hanging onto the wire before P21, at which time approximately 80% of saline-treated WT and DKO animals successfully hung onto the wire for at least 1 s (Fig 2A). Approximately 80% of ethanol-treated DKO animals were also capable of hanging onto the wire, whereas only ~60% of WT mice neonatally exposed to ethanol gripped the wire. At P30, all the animals were capable of hanging onto the wire for at least 1 second, regardless of genotype or neonatal treatment. Although fewer ethanol-exposed WT animals successfully hung on the wire at P21, no significant effect of Genotype or Treatment on the total hang duration was demonstrated between any groups (Fig 2B). Three-way ANOVA with Age (P21 and P30) as the within subjects factor and Genotype and Treatment as the between-groups factors resulted in a significant effect of Age on the total duration of time on the wire [p<0.001; F(1, 20)=16.65].
Figure 2. Effect of postnatal ethanol (EtOH) exposure on the wire suspension and grid hang tests.
(A) Postnatal ethanol exposure decreased the percentage of WT animals capable of holding onto the wire at P21, but had no significant effect on total time on the wire (B) in either genotype. (A score of 0 = unable to hang on, 1 = capable of hanging on for ≥1 second). Mean ± SEM, n=4–8 mice per group. (C) Exposure to 2.5 g/kg EtOH at P6 had no effect on the ability to hang upside down from a wire grid. However, genetic deletion of AC1/8 significantly increased the ability of mice to hang from the wire grid at P21, but not P30. Mean ± SEM, n=5–8 mice per group. *WT vs DKO, irrespective of treatment p<0.05.
3.4 Grid Hang
The ability of the animals to hang from a wire grid was significantly affected by age with a significant increase in the time spent on the grid by WT mice from P14–P30 [p<0.001; F(2, 40)=34.17]. A significant interaction of Age and Genotype [p<0.01; F(2, 40)=6.30] was also observed with post-hoc analysis revealing a significant difference between WT and DKO mice at P21 (p=0.02). At this age, the DKO mice, regardless of neonatal treatment, were capable of hanging on the wire grid longer than WT mice (Fig 2C). No significant effect of ethanol treatment was determined.
3.5 Negative Geotaxis
The percentage of animals capable of turning and climbing up the wire grid (score of 0) increased with age from P7–P14 with no major variations between groups (Fig 3A). At P21 and P30, all animals were capable of climbing the grid (data not shown). The time required for each animal to turn and begin to climb the grid was recorded, however three-way ANOVA analysis was not possible due to a portion of animals not performing the task at each time point. Therefore, all time points were analyzed for the latency to turn using independent two-way ANOVAs. At P7, although a similar percentage of animals were capable of turning and climbing, ethanol-treated DKO animals required significantly more time to turn and climb the grid than all other groups [p=0.04; F(1, 6)=6.34] (Fig 3B). All groups demonstrated improvement in the time required for turning as demonstrated by a reduction in time to turning at P30 and no significant effects were determined at any other time point.
Figure 3. Effect of postnatal ethanol (EtOH) exposure on the development of negative geotaxis.
(A) Percentage of animals displaying the negative geotaxis reflex (turning and climbing the wire grid) from P7–P14 (percent of animals with a score of 0 versus all other scores). (B) The average time required for the mice to turn and begin to climb the wire grid was significantly increase at P7 in DKO mice neonatally exposed to EtOH compared to DKO controls and WT mice neonatally exposed to EtOH. Mean ± SEM, 5–8 mice per group. *WT EtOH vs DKO EtOH, #DKO Saline vs DKO EtOH, p<0.05.
3.6 TST
The total amount of time spent immobile in the TST significantly increased with age [p<0.001; F(2, 42)=27.60] (Fig 4A). A significant main effect of Genotype [p<0.001; F(1, 21)=34.59] and a significant interaction of Genotype × Age [p<0.001; F(2, 42)=16.53] were determined, with the DKO mice spending significantly less time immobile compared to the WT mice at both P21 (p<0.001) and P30 (p<0.001), regardless of neonatal treatment. A significant main effect of Treatment was also demonstrated, with neonatal ethanol exposure significantly decreasing the total immobility time across both genotypes combined [p<0.01; F(1, 21)=8.40]. The presence of hindlimb clasping was also observed during the TST with DKO mice having significantly more clasping events than WT mice [p=0.02; F(1, 25)=5.69] (Fig 4B). Interestingly, only ethanol-exposed WT animals demonstrated hindlimb clasping, whereas DKO mice displayed this behavior regardless of neonatal treatment.
Figure 4. Effect of postnatal ethanol (EtOH) exposure on total immobility time and hindlimb clasping during the tail suspension test.
(A) Genetic deletion of AC1/8 significantly decreased the total immobility time at P21 and P30 compared to WT mice in the presence and absence of EtOH. *WT vs DKO, p<0.05. (B) Saline-treated DKO mice displayed marked hindlimb clasping, which was absent in WT controls. *WT vs DKO, p<0.05. Neonatal EtOH exposure increased the number of clasping events in WT mice, while decreasing this behavior in DKO mice during the TST. Mean ± SEM, n=5–8 mice per group
3.7 Rotarod
Neither exposure to 2.5 g/kg ethanol [p=0.82; F(1, 29)=0.05] nor genetic deletion of AC 1/8 [p=0.56; F(1, 29)=0.34] had any effect on the total time spent on the accelerating rotarod (data not shown).
3.8 LORR
No effect of ethanol treatment was demonstrated in the LORR assay at P30 in either genotype (data not shown). AC1/8 knockout mice trended toward having a greater sedation time after 4.0 g/kg ethanol than WT mice, regardless of neonatal treatment, but this difference failed to reach statistical significance [p=0.059; F12, 23)=59.31].
3.9 LMA
WT mice neonatally exposed to ethanol demonstrated a slight, non-significant increase in locomotor activity following saline injection on day 1 compared to neonatal saline-treated control mice (Fig 5A). No significant differences were observed on days 2–4 (data not shown). On day 5, acute exposure to 2.0 g/kg ethanol modestly, but significantly, increased locomotor activity collectively in both genotypes when normalized to neonatal saline-treated controls (Fig 5B; effect of neonatal Treatment [p=0.008; F(1, 50)=7.65)]. Figure 5C demonstrates the time course following ethanol injection on day 5. Three-way ANOVA analysis (Minute as the within-subjects factor and Genotype and neonatal Treatment as between-subjects factors) revealed a significant main effect of Genotype [p=0.05; F(1, 50)=3.93], neonatal Treatment [p<0.01; F(1, 50)=7.65] and an interaction of Genotype and Treatment [p=0.05; F(1, 50)=3.93], with DKO mice exposed to ethanol as neonates having a greater increase in locomotor activity that peaks 5 min after ethanol injection, compared to ethanol-exposed WT mice. No effect of Minute or Minute interactions were found using the Greenhouse-Geisser correction (χ2 = 189.06, p<0.001, ε = 0.52).
Figure 5. Effect of postnatal ethanol (EtOH) exposure on locomotor activity following acute saline or EtOH challenge.
At P30, animals exposed to neonatal (P5–7) saline or 2.5 g/kg EtOH were acclimated to locomotor chambers for 4 days following saline injections. On day 5, animals were given 2.0 g/kg EtOH i.p. before being placed in the same locomotor chambers. Activity was monitored for 10 min on each day. (A) On day 1, neonatal EtOH exposure marginally increased locomotor activity in WT but not DKO animals. (B) On Day 5, neonatal EtOH treatment significantly increased EtOH-induced locomotor activity compared to saline-treated animals, regardless of genotype. Data represent mean ambulations ± SEM over the 10 min of testing plotted as percent of saline control. *Saline vs EtOH, p<0.05. (C) EtOH-exposed DKO mice show a significant increase in locomotor activity after 2.0 g/kg EtOH exposure on day 5, compared to EtOH-exposed WT mice, peaking at 5 minutes after injection. Data represent mean ambulations ± SEM plotted as percent of saline control in 1 min bins. n=9–20 mice per group. #WT vs DKO p=0.05
4.Discussion
4.1 Developmental Behaviors
In this study, we evaluated the behavior of mice treated postnatally with 2.5 g/kg ethanol as a model of maternal alcohol consumption during the third trimester. Although previous studies using this model have demonstrated substantial cell death in the caudate putaman within 4 h of ethanol treatment [22, 23, 37], here we show that this single dose of ethanol is not sufficient to result in overt behavioral changes in attainment of the postural reflex, grid hang, negative geotaxis or wire suspension in WT mice. The lack of effect of neonatal ethanol exposure in WT mice in this study may be expected given that behavioral deficits in these procedures observed in models of Parkinson’s disease are not evident until more than 80% of striatal dopamine has been lost [26, 38]. Previous studies evaluating developmental behaviors following early life exposure to ethanol demonstrate that rats given 6.6 g/kg/day (P4–P10) ethanol in 4 fractions over 8 h or in 12 fractions over 24 h do not result in deficits in the negative geotaxis task or in the cliff avoidance task [39], similar to our results in WT mice (Fig 3A and B). In addition, mice treated with 5.0 g/kg ethanol, divided into 2 doses, 2 h apart on P7 demonstrated no deficits in the negative geotaxis test with the grid set at a 60° angle at P21 [21]. Conversely, mouse pups from dams given free access to 10% ethanol throughout gestation and the early postpartum period (through P10; ~10–24 g/kg consumption) were significantly delayed in the negative geotaxis, cliff avoidance, and midair righting [40]. These data indicate that these behaviors demonstrate temporal sensitivity, with the vulnerable period occurring prenatally in rodents.
Although behavioral effects were not observed in ethanol-treated WT mice, the increase in cell death demonstrated previously following neonatal ethanol exposure in DKO mice [23] was hypothesized to induce behavioral deficiencies compared to WT controls. In support of this hypothesis, ethanol-exposed DKO animals demonstrated a deficiency in the negative geotaxis task, with saline-treated DKO and ethanol-treated WT animals completing this task in ~5 s at P7 and the DKO ethanol group requiring ~12 s (Fig 3B). The latency to turn decreased with age in both genotypes, however at P30 ethanol-exposed DKO mice required twice as much time as all the other groups to turn and climb. What is most surprising with this data is the fact that although the latency to turn for the ethanol-exposed DKO group was higher than WT, a higher percentage of DKO mice accomplished the task at P30 than the WT group. The discrepancy between WT and DKO animals in latency to turn may relate to the significant increase in striatal cell death compared to ethanol treated WT controls [23], indicating a possible threshold for neurodegeneration for behavioral effects. In addition, this discrepancy could be the result of a disruption in normal development caused by the lack of AC activity throughout gestational development in the DKO mice, making the ethanol exposure used here mimic the delay in negative geotaxis observed by Kleiber and colleagues following prenatal exposure in WT animals [40].
Our results also indicate no effect of neonatal ethanol treatment on grid hang (Fig 2C) or wire suspension (Fig 2B) in WT animals. DKO animals, however, displayed significantly increased hang time in the grid hang test, which is not speculated to be due to a difference in muscle strength as there was no significant genotypic difference in the wire suspension test. DKO mice also displayed significantly decreased immobility duration during TST (Fig 4), regardless of neonatal treatment. A similar decrease in immobility time was found in animals with a conventional deletion in 2 prominent cAMP response element-binding protein (CREB) isoforms or mice transfected with dominant negative CREB in the nucleus accumbens shell [41, 42], suggesting that the cAMP/PKA/CREB pathway is compromised in these mice. Consistent with this finding, mice lacking AC8 show reductions in CREB phosphorylation in the CA1 region of the hippocampus after stress [43]. Studies have suggested that CREB activity is crucial during neuronal development (reviewed in [44]) and for Brain Derived Neurotrophic Factor (BDNF) transcription [45, 46]. Interestingly, mice genetically altered to lack BDNF in the forebrain demonstrate hindlimb clasping [47], a phenotype similar to that currently demonstrated by DKO mice. A lack of effect of forebrain BDNF deletion on accelerating rotarod performance [47] further parallels behaviors exhibited by DKO mice in the present study. Further, deficiencies in forebrain BDNF confers a reduction in both striatal and cortical volume at P14, 35 and 120 [47], similar to that observed in animal models of FASD [21, 48] and in the clinically affected population [12, 49–53]. Previous studies in animal models have also shown reductions in BDNF expression after neonatal ethanol exposure in cortex [54–58] and cerebellum [59]. Although studies of gestational ethanol exposure have failed to show a change in BDNF levels in the striatum [57, 60], there may be temporal vulnerability of BDNF expression in the striatum, similar to that observed in the cerebellum [61], which warrant further investigation of postnatal ethanol exposure in both WT and DKO mice.
4.2 Rotarod
Similar to the results described here, previous studies of neonatal ethanol exposure have failed to show changes in rotarod performance at P18, P28 or P48 after exposure to 2.15% or 2.5% ethanol (P4–P12) [62]. Diaz et al. also did not observe an effect of postnatal ethanol on rotarod performance at P21–P23 after exposure to ethanol vapor for 4 h from P2–P12 [63]. Similarly, Dursun et al. failed to detect a significant effect of neonatal ethanol exposure in P90–P95 rats previously treated with 6 g/kg ethanol from gestational day (G) 7 to G20 [64]. However, rats exposed to 4.5 g/kg ethanol using 10.2% ethanol in 2 feedings over P4–P9 performed significantly worse on a rotarod task at approximately 405 days of age than rats exposed to 4.5 g/kg ethanol using 5.1% ethanol in 4 feedings or pair-fed controls [65]. The differences between these results is suggested to be related to the peak BAC and resulting neuronal loss, which is more pronounced in the condensed feeding paradigm [65]. These authors also speculate that the differences observed between their study and that by Meyer et al. [62] are due to differences in the age at testing or method of testing with the rotarod used in the Meyer et al. study having a 15 cm diameter rod which may not have been challenging enough to discern impairments imposed by previous ethanol exposure (7 cm diameter used in their study). In the study by Dursun et al., a rotarod with a diameter of 6.5 cm was used, but the rotarod was set at 20 revolutions per minute throughout the testing procedure, whereas the others accelerated throughout the test. Our study also used an accelerating paradigm but no effects of neonatal ethanol exposure were observed, which may be due to the single, lower dose of postnatal ethanol, compared to the procedure used by Goodlett et al. Another important difference is the age at testing, as the rats used by Goodlett et al. were over a year old, while our mice were tested at P30, perhaps suggesting that deficits in motor performance on the rotarod caused by postnatal ethanol exposure require a longer time to develop.
4.3 Loss of Righting Reflex
Previous work has demonstrated that rats exposed to ethanol throughout gestation and lactation are less sensitive to the sedative effects of 4.0 g/kg ethanol at P60 [66], contrary to the LORR results here showing no effect of postnatal ethanol exposure. However, the rats used by Barbier et al. were exposed to higher levels of ethanol throughout their neurodevelopment, with dams consuming 8–20 g/kg ethanol (throughout gestation and lactation). These data indicate increased sensitivity to ethanol sedation in mature animals is dependent on either the timing or dose of developmental ethanol exposure. Although DKO mice were shown to be more sensitive to the neurodegenerative effects of neonatal ethanol exposure [17, 23] the degenerative effects of the ethanol dose used may not have reached the threshold required to affect ethanol-induced sedation. It should be noted that although previous studies in DKO mice have demonstrated an increase in sedation time following 4.0 g/kg ethanol [33], only a trend toward an increase in sedation was observed in the current study. One potential explanation for this discrepancy is the age at testing, as the mice used in the current study were tested at P30, while previous work was performed in adult mice (2–4 months) [33] and duration of LORR is known to increase with age [67, 68].
4.4 Locomotor Activity
LMA has been extensively studied following both pre- and post-natal ethanol treatment, although the results vary. For example, rats given 6.6 g/kg/day ethanol in 4 fractions over 8 h on P4–P10 were significantly more active in an open field at P20 than controls or rats given 6.6 g/kg/day in 12 fractions over 24 h daily from P4–P10 [39]. In a similar study, rats given 6.0 g/kg/day ethanol in 4 feedings over 4 h from P4–P10 were also significantly more active in a 30 min open field test in a novel chamber on P18 [69]. Comparable studies in mice have also shown increases in activity, for instance, pups born from mice given free access to 10% ethanol for the first 8 days of gestation were significantly more active in the first 10 min in an open field on P14 and P21 compared to water controls [70]. No significant differences in the activity during the remaining 20 min was observed [70]. Mice treated with 5.0 g/kg ethanol, divided into 2 doses, 2 h apart on P7 were significantly more active in a 1 h open field test at P70 [21].
In contrast, mouse pups from dams given free access to 10% ethanol through gestation and the early postpartum period (through P10; ~10–23 g/kg/day consumption) were significantly less active during a locomotor activity test (15 min) in a novel environment at P25, with no significant effect of general locomotor activity in their home cages over the 12 h dark phase at P34 [40]. Similarly, P80–P85 rats previously treated with 6 g/kg ethanol from G7 to G20 demonstrated a significant decrease in locomotor activity for the first 5 min in a novel open field chamber, with no significant effects for the remaining 25 min [64]. Lucchi et al. also demonstrated that pups born from dams given ethanol from G5 throughout pregnancy were significantly less active than control pups or pups who were exposed to ethanol during lactation [71].
Consistent with our present results in P30 mice following a single postnatal exposure to ethanol (Day 1; Fig 5A), some studies have found no effect of ethanol exposure on LMA behavior. For instance, pups from dams receiving 20 or 25% of their calories from ethanol from G5 through G18 did not display significantly different activity from controls at P12, P20, P28, or P36 in an open field paradigm [72]. In addition, exposure to 5 g/kg ethanol on P7 in 2 doses of 2.5 g/kg given 2 h apart had no effect on locomotor activity in rats examined in an open field for 35 min at P35 [73]. Likewise, mice treated with 5.0 g/kg ethanol, divided into 2 doses, 2 h apart on P7 displayed no significant effects on locomotor activity in an open field test for 1 h at P21 [21].
From these studies, it is difficult to determine which ethanol treatment is more likely to contribute to disturbances in LMA. However, Tran and colleagues endeavored to parse out these differences by treating mice from G2 through G10, G11 to G22, P2 through P10, or all three time periods. For the gestational exposures, pregnant dams were administered 4.5 g/kg/day ethanol, while pups were given 3.0 g/kg/day ethanol, both through intragastric gavage [74]. These authors only observed an increase in activity at P16 in the 2 groups exposed to ethanol during G11 to G22, whereas ethanol exposure during the postnatal period (P2–P10) alone increased activity in adult (P91) rats [74]. One major difference between this study and others is that Tran et al. performed the LMA testing on 2 consecutive days for both juveniles (P15–P16) and adults (P90–P91), and only observed differences on the second day of testing in both ages. Unfortunately the variability in results of these studies, and the multitude of others examining LMA, make generalizations difficult. There are many differences between these studies, including timing, dose, and route of ethanol exposure, variations in LMA paradigms and ages at testing. Also, the stress to the animal should be taken into consideration as some of these studies use artificial rearing procedures that segregate the pup from the lactating dam for extended periods.
In addition to general LMA, activity after administration of 2.0 g/kg ethanol was examined in the present study and shown to be increased following neonatal ethanol treatment (Fig 5B). In contrast, Barbier et al. demonstrated no effect of ethanol exposure throughout gestation and lactation on ethanol-induced LMA at P60 in male rats [66]. The differences in results between these two studies may relate to the increased sensitivity of the DKO mice to neonatal ethanol exposure. Previous studies in adult DKO animals have shown an attenuated effect of acute ethanol exposure to stimulate LMA compared to WT animals [34]. Here, we show a significantly augmented response to acute ethanol in DKO animals treated with ethanol postnatally compared to postnatal ethanol-treated WT mice. Previous studies in animals have also demonstrated an increased propensity for ethanol intake in adolescent and adult animals neonatally exposed to ethanol (reviewed in [75]). The lower threshold for the locomotor stimulating effects of ethanol after neonatal ethanol exposure poise the DKO mice to be interesting candidates for future studies on other measures of ethanol sensitivity including voluntary consumption.
5. Conclusion
In this study, we examined the behavioral effects of postnatal ethanol exposure in WT and AC1/8 knockout mice at discrete developmental time points. Our results overall demonstrate a reduction in immobility time as well as an increase in hindlimb clasping in DKO mice regardless of postnatal ethanol exposure during the TST test, indicating a possible difference in CREB and/or BDNF activity in these mice. We also demonstrate behavioral effects of neonatal ethanol in the negative geotaxis test and the locomotor response to ethanol during adolescence in DKO mice, indicative of an altered threshold for sensitivity to ethanol’s effect on these behaviors in mice lacking AC1 and 8. Future studies will explore mechanisms involving AC1/8 deletion on ethanol consumption and measures of ethanol-induced plasticity in the neonatally-exposed adolescent.
Highlights.
Select striatal behaviors may be insensitive for detecting early alcohol exposure
Adenylyl cyclase 1/8 moderate alcohol-induced activity after early alcohol exposure
Adenylyl cyclase 1/8 loss induces behaviors suggesting impaired striatal signaling
Acknowledgements
The authors would like to thank Drs. Shane Perrine and Matthew Galloway for the use and technical support of the locomotor activity chambers and the Research Design and Analysis Consulting Unit at Wayne State University for their insight on the statistical analysis.
Funding Source: This material is the result of work supported with resources and the use of facilities at the John D. Dingell VA Medical Center, Detroit, MI and by funds from Wayne State University Department of Neurosurgery (ACC) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) grants F32 AA020435 (LLS) and K01 AA017683 (ACC). These sponsors had no involvement in study design, collection, analysis, or interpretation of the data or submission of the manuscript for publication.
Abbreviations
- AC
Adenylyl Cyclase
- ANOVA
Analysis of Variance
- BAC
Blood Alcohol Concentration
- BDNF
Brain Derived Neurotrophic Factor
- cAMP
cyclic adenosine monophosphate
- CREB
cAMP Response Element-Binding Protein
- DKO
Double Knockout (adenylyl cyclases 1/8)
- EtOH
Ethanol
- FASD
Fetal Alcohol Spectrum Disorders
- G
Gestational Day
- i.p
Intraperitoneally
- LMA
Locomotor Activity
- LORR
Loss of Righting Reflex
- P
Postnatal day
- PKA
Protein Kinase A
- TST
Tail Suspension Test
- WS
Wire Suspension
- WT
Wild Type
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Contributor Information
Laura L. Susick, Email: LSusick@med.wayne.edu.
Jennifer L. Lowing, Email: JLowing@med.wayne.edu.
Kelly E. Bosse, Email: KBosse@med.wayne.edu.
Clara C. Hildebrandt, Email: CHildebr@med.wayne.edu.
Alexandria C. Chrumka, Email: Alexandria.Chrumka@yahoo.com.
Alana C. Conti, Email: AConti@med.wayne.edu.
References
- 1.Sokol RJ, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA. 2003;290(22):2996–2999. doi: 10.1001/jama.290.22.2996. [DOI] [PubMed] [Google Scholar]
- 2.Breiner P, Nulman I, Koren G. Identifying the neurobehavioral phenotype of fetal alcohol spectrum disorder in young children. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique. 2013;20(3):e334–e339. doi: [PubMed] [Google Scholar]
- 3.Guerri C, Bazinet A, Riley EP. Foetal Alcohol Spectrum Disorders and alterations in brain and behaviour. Alcohol Alcohol. 2009;44(2):108–114. doi: 10.1093/alcalc/agn105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jones KL. The effects of alcohol on fetal development. Birth defects research. Part C, Embryo today : reviews. 2011;93(1):3–11. doi: 10.1002/bdrc.20200. [DOI] [PubMed] [Google Scholar]
- 5.Kodituwakku PW. Defining the behavioral phenotype in children with fetal alcohol spectrum disorders: a review. Neurosci Biobehav Rev. 2007;31(2):192–201. doi: 10.1016/j.neubiorev.2006.06.020. [DOI] [PubMed] [Google Scholar]
- 6.Koren G, Zelner I, Nash K, Koren G. Foetal alcohol spectrum disorder: identifying the neurobehavioural phenotype and effective interventions. Current opinion in psychiatry. 2014;27(2):98–104. doi: 10.1097/YCO.0000000000000038. [DOI] [PubMed] [Google Scholar]
- 7.Mattson SN, Crocker N, Nguyen TT. Fetal alcohol spectrum disorders: neuropsychological and behavioral features. Neuropsychology review. 2011;21(2):81–101. doi: 10.1007/s11065-011-9167-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nash K, Stevens S, Rovet J, Fantus E, Nulman I, Sorbara D, Koren G. Towards identifying a characteristic neuropsychological profile for fetal alcohol spectrum disorders. 1. Analysis of the Motherisk FASD clinic. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique. 2013;20(1):e44–e52. [PubMed] [Google Scholar]
- 9.Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders: an overview. Neuropsychology review. 2011;21(2):73–80. doi: 10.1007/s11065-011-9166-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet. 1973;302(7836):999–1001. doi: 10.1016/s0140-6736(73)91092-1. [DOI] [PubMed] [Google Scholar]
- 11.Jones KL, Smith DW. The fetal alcohol syndrome. Teratology. 1975;12(1):1–10. doi: 10.1002/tera.1420120102. [DOI] [PubMed] [Google Scholar]
- 12.Norman AL, Crocker N, Mattson SN, Riley EP. Neuroimaging and fetal alcohol spectrum disorders. Dev Disabil Res Rev. 2009;15(3):209–217. doi: 10.1002/ddrr.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Coleman LG, Jr, Oguz I, Lee J, Styner M, Crews FT. Postnatal day 7 ethanol treatment causes persistent reductions in adult mouse brain volume and cortical neurons with sex specific effects on neurogenesis. Alcohol. 2012 doi: 10.1016/j.alcohol.2012.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Gonzalez-Burgos I, Alejandre-Gomez M, Olvera-Cortes ME, Perez-Vega MI, Evans S, Feria-Velasco A. Prenatal-through-postnatal exposure to moderate levels of ethanol leads to damage on the hippocampal CA1 field of juvenile rats: a stereology and Golgi study. Neurosci Res. 2006;56(4):400–408. doi: 10.1016/j.neures.2006.08.007. [DOI] [PubMed] [Google Scholar]
- 15.Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW. Ethanol-induced apoptotic neurodegeneration and the fetal alcohol syndrome. Science. 2000;287:1056–1060. doi: 10.1126/science.287.5455.1056. [DOI] [PubMed] [Google Scholar]
- 16.Leigland LA, Ford MM, Lerch JP, Kroenke CD. The influence of fetal ethanol exposure on subsequent development of the cerebral cortex as revealed by magnetic resonance imaging. Alcohol Clin Exp Res. 2013;37(6):924–932. doi: 10.1111/acer.12051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Maas JW, Jr, Indacochea RA, Muglia LM, Tran TT, Vogt SK, West T, Benz A, Shute AA, Holtzman DM, Mennerick S, Olney JW, Muglia LJ. Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain. J Neurosci. 2005;25(9):2376–2385. doi: 10.1523/JNEUROSCI.4940-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Maier SE, West JR. Regional differences in cell loss associated with binge-like alcohol exposure during the first two trimesters equivalent in the rat. Alcohol. 2001;23(1):49–57. doi: 10.1016/s0741-8329(00)00133-6. [DOI] [PubMed] [Google Scholar]
- 19.Olney JW, Ishimaru MJ, Bittigau P, Ikonomidou C. Ethanol-induced apoptotic neurodegeneration in the developing brain. Apoptosis : an international journal on programmed cell death. 2000;5(6):515–521. doi: 10.1023/a:1009685428847. [DOI] [PubMed] [Google Scholar]
- 20.Olney JW. New insights and new issues in developmental neurotoxicology. Neurotoxicology. 2002;23(6):659–668. doi: 10.1016/S0161-813X(01)00092-4. [DOI] [PubMed] [Google Scholar]
- 21.Wozniak DF, Hartman RE, Boyle MP, Vogt SK, Brooks AR, Tenkova T, Young C, Olney JW, Muglia LJ. Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol Dis. 2004;17(3):403–414. doi: 10.1016/j.nbd.2004.08.006. [DOI] [PubMed] [Google Scholar]
- 22.Young C, Olney JW. Neuroapoptosis in the infant mouse brain triggered by a transient small increase in blood alcohol concentration. Neurobiol Dis. 2006;22(3):548–554. doi: 10.1016/j.nbd.2005.12.015. [DOI] [PubMed] [Google Scholar]
- 23.Conti AC, Young C, Olney JW, Muglia LJ. Adenylyl cyclases types 1 and 8 promote pro-survival pathways after ethanol exposure in the neonatal brain. Neurobiol Dis. 2009;33(1):111–118. doi: 10.1016/j.nbd.2008.09.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Green CR, Mihic AM, Nikkel SM, Stade BC, Rasmussen C, Munoz DP, Reynolds JN. Executive function deficits in children with fetal alcohol spectrum disorders (FASD) measured using the Cambridge Neuropsychological Tests Automated Battery (CANTAB) Journal of child psychology and psychiatry, and allied disciplines. 2009;50(6):688–697. doi: 10.1111/j.1469-7610.2008.01990.x. [DOI] [PubMed] [Google Scholar]
- 25.Rasmussen C. Executive functioning and working memory in fetal alcohol spectrum disorder. Alcohol Clin Exp Res. 2005;29(8):1359–1367. doi: 10.1097/01.alc.0000175040.91007.d0. [DOI] [PubMed] [Google Scholar]
- 26.Tillerson JL, Caudle WM, Reveron ME, Miller GW. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyI-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol. 2002;178(1):80–90. doi: 10.1006/exnr.2002.8021. [DOI] [PubMed] [Google Scholar]
- 27.Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neurosci Methods. 2003;123(2):189–200. doi: 10.1016/s0165-0270(02)00360-6. [DOI] [PubMed] [Google Scholar]
- 28.Carneiro LM, Diogenes JP, Vasconcelos SM, Aragao GF, Noronha EC, Gomes PB, Viana GS. Behavioral and neurochemical effects on rat offspring after prenatal exposure to ethanol. Neurotoxicol Teratol. 2005;27(4):585–592. doi: 10.1016/j.ntt.2005.06.006. [DOI] [PubMed] [Google Scholar]
- 29.Smith AM, Wellmann KA, Lundblad TM, Carter ML, Barron S, Dwoskin LP. Lobeline attenuates neonatal ethanol-mediated changes in hyperactivity and dopamine transporter function in the prefrontal cortex in rats. Neuroscience. 2012;206:245–254. doi: 10.1016/j.neuroscience.2011.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Alfonso-Loeches S, Guerri C. Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Critical reviews in clinical laboratory sciences. 2011;48(1):19–47. doi: 10.3109/10408363.2011.580567. [DOI] [PubMed] [Google Scholar]
- 31.Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J Comp Neurol. 2005;490(4):354–370. doi: 10.1002/cne.20680. [DOI] [PubMed] [Google Scholar]
- 32.Conti AC, Maas JW, Jr, Moulder KL, Jiang X, Dave BA, Mennerick S, Muglia LJ. Adenylyl cyclases 1 and 8 initiate a presynaptic homeostatic response to ethanol treatment. PLoS One. 2009;4(5):e5697. doi: 10.1371/journal.pone.0005697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Maas JW, Jr, Vogt SK, Chan GC, Pineda VV, Storm DR, Muglia LJ. Calcium-stimulated adenylyl cyclases are critical modulators of neuronal ethanol sensitivity. J Neurosci. 2005;25(6):4118–4126. doi: 10.1523/JNEUROSCI.4273-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Conti AC, Lowing JL, Susick LL, Bowen SE. Investigation of calcium-stimulated adenylyl cyclases 1 and 8 on toluene and ethanol neurobehavioral actions. Neurotoxicol Teratol. 2012;34(5):481–488. doi: 10.1016/j.ntt.2012.06.005. [DOI] [PubMed] [Google Scholar]
- 35.Susick LL, Lowing JL, Provenzano AM, Hildebrandt CC, Conti AC. Postnatal Ethanol Exposure Simplifies the Dendritic Morphology of Medium Spiny Neurons Independently of Adenylyl Cyclase 1 and 8 Activity in Mice. Alcohol Clin Exp Res. 2014 doi: 10.1111/acer.12383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci. 2002;22(8):3262–3268. doi: 10.1523/JNEUROSCI.22-08-03262.2002. doi: 0270-6474/02/223262-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Olney JW, Tenkova T, Dikranian K, Muglia LJ, Jermakowicz WJ, D'Sa C, Roth KA. Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol Dis. 2002;9(2):205–219. doi: 10.1006/nbdi.2001.0475. [DOI] [PubMed] [Google Scholar]
- 38.Golden JP, Demaro JA, 3rd, Knoten A, Hoshi M, Pehek E, Johnson EM, Jr, Gereau RWt, Jain S. Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons. J Neurosci. 2013;33(43):17095–17107. doi: 10.1523/JNEUROSCI.0890-13.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Kelly SJ, Hulsether SA, West JR. Alterations in sensorimotor development: relationship to postnatal alcohol exposure. Neurotoxicol Teratol. 1987;9(3):243–251. doi: 10.1016/0892-0362(87)90009-2. [DOI] [PubMed] [Google Scholar]
- 40.Kleiber ML, Wright E, Singh SM. Maternal voluntary drinking in C57BL/6J mice: advancing a model for fetal alcohol spectrum disorders. Behav Brain Res. 2011;223(2):376–387. doi: 10.1016/j.bbr.2011.05.005. [DOI] [PubMed] [Google Scholar]
- 41.Conti AC, Blendy JA. Regulation of antidepressant activity by cAMP response element binding proteins. Mol Neurobiol. 2004;30(2):143–155. doi: 10.1385/MN:30:2:143. [DOI] [PubMed] [Google Scholar]
- 42.Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA., Jr Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci. 2001;21(18):7397–7403. doi: 10.1523/JNEUROSCI.21-18-07397.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Schaefer ML, Wong ST, Wozniak DF, Muglia LM, Liauw JA, Zhuo M, Nardi A, Hartman RE, Vogt SK, Luedke CE, Storm DR, Muglia LJ. Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci. 2000;20(13):4809–4820. doi: 10.1523/JNEUROSCI.20-13-04809.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002;35(4):605–623. doi: 10.1016/s0896-6273(02)00828-0. [DOI] [PubMed] [Google Scholar]
- 45.Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 1998;20(4):709–726. doi: 10.1016/s0896-6273(00)81010-7. [DOI] [PubMed] [Google Scholar]
- 46.Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron. 1998;20(4):727–740. doi: 10.1016/s0896-6273(00)81011-9. [DOI] [PubMed] [Google Scholar]
- 47.Baquet ZC, Gorski JA, Jones KR. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci. 2004;24(17):4250–4258. doi: 10.1523/JNEUROSCI.3920-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Olney JW, Tenkova T, Dikranian K, Qin YQ, Labruyere J, Ikonomidou C. Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res. 2002;133(2):115–126. doi: 10.1016/s0165-3806(02)00279-1. [DOI] [PubMed] [Google Scholar]
- 49.Mattson SN, Riley EP, Jernigan TL, Garcia A, Kaneko WM, Ehlers CL, Jones KL. A decrease in the size of the basal ganglia following prenatal alcohol exposure: a preliminary report. Neurotoxicol Teratol. 1994;16(3):283–289. doi: 10.1016/0892-0362(94)90050-7. [DOI] [PubMed] [Google Scholar]
- 50.Mattson SN, Riley EP, Sowell ER, Jernigan TL, Sobel DF, Jones KL. A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. Alcohol Clin Exp Res. 1996;20(6):1088–1093. doi: 10.1111/j.1530-0277.1996.tb01951.x. [DOI] [PubMed] [Google Scholar]
- 51.Nardelli A, Lebel C, Rasmussen C, Andrew G, Beaulieu C. Extensive deep gray matter volume reductions in children and adolescents with fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2011;35(8):1404–1417. doi: 10.1111/j.1530-0277.2011.01476.x. [DOI] [PubMed] [Google Scholar]
- 52.Treit S, Lebel C, Baugh L, Rasmussen C, Andrew G, Beaulieu C. Longitudinal MRI reveals altered trajectory of brain development during childhood and adolescence in fetal alcohol spectrum disorders. J Neurosci. 2013;33(24):10098–10109. doi: 10.1523/JNEUROSCI.5004-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Zhou D, Lebel C, Lepage C, Rasmussen C, Evans A, Wyper K, Pei J, Andrew G, Massey A, Massey D, Beaulieu C. Developmental cortical thinning in fetal alcohol spectrum disorders. Neuroimage. 2011;58(1):16–25. doi: 10.1016/j.neuroimage.2011.06.026. [DOI] [PubMed] [Google Scholar]
- 54.Climent E, Pascual M, Renau-Piqueras J, Guerri C. Ethanol exposure enhances cell death in the developing cerebral cortex: role of brain-derived neurotrophic factor and its signaling pathways. J Neurosci Res. 2002;68(2):213–225. doi: 10.1002/jnr.10208. [DOI] [PubMed] [Google Scholar]
- 55.Heaton MB, Paiva M, Madorsky I, Shaw G. Ethanol effects on neonatal rat cortex: comparative analyses of neurotrophic factors, apoptosis-related proteins, and oxidative processes during vulnerable and resistant periods. Brain Res Dev Brain Res. 2003;145(2):249–262. doi: 10.1016/j.devbrainres.2003.08.005. [DOI] [PubMed] [Google Scholar]
- 56.Tsuji R, Fattori V, Abe S, Costa LG, Kobayashi K. Effects of postnatal ethanol exposure at different developmental phases on neurotrophic factors and phosphorylated proteins on signal transductions in rat brain. Neurotoxicol Teratol. 2008;30(3):228–236. doi: 10.1016/j.ntt.2008.01.004. [DOI] [PubMed] [Google Scholar]
- 57.Feng MJ, Yan SE, Yan QS. Effects of prenatal alcohol exposure on brain-derived neurotrophic factor and its receptor tyrosine kinase B in offspring. Brain Res. 2005;1042(2):125–132. doi: 10.1016/j.brainres.2005.02.017. [DOI] [PubMed] [Google Scholar]
- 58.Fattori V, Abe S, Kobayashi K, Costa LG, Tsuji R. Effects of postnatal ethanol exposure on neurotrophic factors and signal transduction pathways in rat brain. J Appl Toxicol. 2008;28(3):370–376. doi: 10.1002/jat.1288. [DOI] [PubMed] [Google Scholar]
- 59.Light KE, Brown DP, Newton BW, Belcher SM, Kane CJ. Ethanol-induced alterations of neurotrophin receptor expression on Purkinje cells in the neonatal rat cerebellum. Brain Res. 2002;924(1):71–81. doi: 10.1016/s0006-8993(01)03224-3. [DOI] [PubMed] [Google Scholar]
- 60.Heaton MB, Paiva M, Madorsky I, Mayer J, Moore DB. Effects of ethanol on neurotrophic factors, apoptosis-related proteins, endogenous antioxidants, and reactive oxygen species in neonatal striatum: relationship to periods of vulnerability. Brain Res Dev Brain Res. 2003;140(2):237–252. doi: 10.1016/s0165-3806(02)00610-7. [DOI] [PubMed] [Google Scholar]
- 61.Heaton MB, Mitchell JJ, Paiva M. Ethanol-induced alterations in neurotrophin expression in developing cerebellum: relationship to periods of temporal susceptibility. Alcohol Clin Exp Res. 1999;23(10):1637–1642. [PubMed] [Google Scholar]
- 62.Meyer LS, Kotch LE, Riley EP. Neonatal ethanol exposure: functional alterations associated with cerebellar growth retardation. Neurotoxicol Teratol. 1990;12(1):15–22. doi: 10.1016/0892-0362(90)90107-n. [DOI] [PubMed] [Google Scholar]
- 63.Diaz MR, Vollmer CC, Zamudio-Bulcock PA, Vollmer W, Blomquist SL, Morton RA, Everett JC, Zurek AA, Yu J, Orser BA, Valenzuela CF. Repeated intermittent alcohol exposure during the third trimester-equivalent increases expression of the GABAA receptor δ subunit in cerebellar granule neurons and delays motor development in rats. Neuropharmacology. 2014;79(0):262–274. doi: 10.1016/j.neuropharm.2013.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Dursun I, Jakubowska-Dogru E, Uzbay T. Effects of prenatal exposure to alcohol on activity, anxiety, motor coordination, and memory in young adult Wistar rats. Pharmacol Biochem Behav. 2006;85(2):345–355. doi: 10.1016/j.pbb.2006.09.001. [DOI] [PubMed] [Google Scholar]
- 65.Goodlett CR, Thomas JD, West JR. Long-term deficits in cerebellar growth and rotarod performance of rats following "binge-like" alcohol exposure during the neonatal brain growth spurt. Neurotoxicol Teratol. 1991;13(1):69–74. doi: 10.1016/0892-0362(91)90029-v. [DOI] [PubMed] [Google Scholar]
- 66.Barbier E, Houchi H, Warnault V, Pierrefiche O, Daoust M, Naassila M. Effects of prenatal and postnatal maternal ethanol on offspring response to alcohol and psychostimulants in long evans rats. Neuroscience. 2009;161(2):427–440. doi: 10.1016/j.neuroscience.2009.03.076. [DOI] [PubMed] [Google Scholar]
- 67.Abel EL. Effects of ethanol and pentobarbital in mice of different ages. Psychobiology. 1978;6(3):366–368. [Google Scholar]
- 68.Quoilin C, Didone V, Tirelli E, Quertemont E. Chronic tolerance to ethanol-induced sedation: implication for age-related differences in locomotor sensitization. Alcohol. 2013;47(4):317–322. doi: 10.1016/j.alcohol.2013.01.006. [DOI] [PubMed] [Google Scholar]
- 69.Thomas JD, Leany BD, Riley EP. Differential vulnerability to motor deficits in second replicate HAS and LAS rats following neonatal alcohol exposure. Pharmacology Biochemistry and Behavior. 2003;75(1):17–24. doi: 10.1016/s0091-3057(03)00031-5. [DOI] [PubMed] [Google Scholar]
- 70.Sanchez Vega MC, Chong S, Burne TH. Early gestational exposure to moderate concentrations of ethanol alters adult behaviour in C57BL/6J mice. Behav Brain Res. 2013;252:326–333. doi: 10.1016/j.bbr.2013.06.003. [DOI] [PubMed] [Google Scholar]
- 71.Lucchi L, Covelli V, Petkov VV, Spano PF, Trabucchi M. Effects of ethanol, given during pregnancy, on the offspring dopaminergic system. Pharmacol Biochem Behav. 1983;19(4):567–570. doi: 10.1016/0091-3057(83)90328-3. [DOI] [PubMed] [Google Scholar]
- 72.Middaugh LD, Randall CL, Favara JP. Prenatal ethanol exposure in C57 mice: effects on pregnancy and offspring development. Neurotoxicol Teratol. 1988;10(2):175–180. doi: 10.1016/0892-0362(88)90082-7. [DOI] [PubMed] [Google Scholar]
- 73.Röskam S, Koch M. Effects of neonatal and peripubertal ethanol treatment on various aspects of adult rat behavior and brain anatomy. International Journal of Developmental Neuroscience. 2009;27(3):249–256. doi: 10.1016/j.ijdevneu.2008.12.009. [DOI] [PubMed] [Google Scholar]
- 74.Tran TD, Cronise K, Marino MD, Jenkins WJ, Kelly SJ. Critical periods for the effects of alcohol exposure on brain weight, body weight, activity and investigation. Behav Brain Res. 2000;116(1):99–110. doi: 10.1016/s0166-4328(00)00263-1. [DOI] [PubMed] [Google Scholar]
- 75.Chotro MG, Arias C, Laviola G. Increased ethanol intake after prenatal ethanol exposure: studies with animals. Neurosci Biobehav Rev. 2007;31(2):181–191. doi: 10.1016/j.neubiorev.2006.06.021. [DOI] [PubMed] [Google Scholar]





